...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Vascular and endovascular surgery >Treatment of type II endoleaks with ethylene-vinyl-alcohol copolymer (Onyx)
【24h】

Treatment of type II endoleaks with ethylene-vinyl-alcohol copolymer (Onyx)

机译：用乙烯-乙烯醇共聚物（Onyx）处理II型内漏

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

We report our single-center experience in treating 101 type II endoleaks with ethylene-vinyl-alcohol copolymer (EVOH, Onyx). In all, 65 endoleaks were embolized transarterially, and 36 were treated through a translumbar approach. Since the first transarterial embolization, when we began attempts to treat all patients initially via common femoral access, 58 (65.9%) of 88 patients were successfully embolized transarterially. All endoleaks in the translumbar group were successfully treated. At a median follow-up length of 15 weeks, a decrease or stabilization in aneurysm size was observed in 39 (73.6%) of the 53 endoleaks that had adequate follow-up computed tomography imaging. The overall residual endoleak rate was 34.0%. There was no difference in efficacy when comparing transarterial and translumbar approaches. We demonstrate that in most cases, transarterial access of the endoleak nidus is feasible, and controlled embolization is possible using EVOH. Furthermore, EVOH appears effective in long-term stabilization of aneurysm size and in preventing residual endoleaks.
机译：我们报告了使用乙烯-乙烯醇共聚物（EVOH，玛瑙）处理101种II型内漏的单中心经验。总共有65个内漏经动脉栓塞，并通过经腰椎入路治疗了36个。自从第一次经动脉栓塞以来，当我们开始尝试首先通过股总入路治疗所有患者时，在88例患者中有58例（65.9％）成功经动脉栓塞。经腰椎组的所有内漏均得到成功治疗。在中位随访期为15周时，在53例进行了适当的计算机断层扫描显像的内漏中，有39例（73.6％）观察到动脉瘤大小减小或稳定。总体残余内漏率为34.0％。比较经动脉和经腰椎入路的疗效无差异。我们证明，在大多数情况下，内漏性病灶的经动脉通路是可行的，并且使用EVOH可以控制栓塞。此外，EVOH在长期稳定动脉瘤大小和防止残留内漏方面似乎是有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号